S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54

Chemours Stock Forecast, Price & News

+0.38 (+1.21%)
(As of 06/28/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.69 million shs
Average Volume
1.86 million shs
Market Capitalization
$4.93 billion
P/E Ratio
Dividend Yield
Price Target
30 days | 90 days | 365 days | Advanced Chart

Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Stock Forecast (MarketRank)

Overall MarketRank

3.24 out of 5 stars

Basic Materials Sector

14th out of 247 stocks

Chemicals & Allied Products Industry

1st out of 20 stocks

Analyst Opinion: 3.2Community Rank: 4.3Dividend Strength: 2.5Insider Behavior: 2.5Valuation: 3.8 5 -4 -3 -2 -1 -
Chemours logo

About Chemours (NYSE:CC)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

CC Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Chemicals & allied products
Year Founded

Company Calendar

Last Earnings
Ex-Dividend for 6/15 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
5 Analysts


Net Income
$608 million
Pretax Margin


Sales & Book Value

Annual Sales
$6.35 billion
Cash Flow
$6.17 per share
Book Value
$6.64 per share


Free Float
Market Cap
$4.93 billion

Chemours Frequently Asked Questions

Should I buy or sell Chemours stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Chemours stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View analyst ratings for Chemours
or view top-rated stocks.

What is Chemours' stock price forecast for 2022?

5 brokers have issued twelve-month price targets for Chemours' shares. Their CC stock forecasts range from $30.00 to $48.00. On average, they anticipate Chemours' share price to reach $40.83 in the next twelve months. This suggests a possible upside of 28.7% from the stock's current price.
View analysts' price targets for Chemours
or view top-rated stocks among Wall Street analysts.

How has Chemours' stock price performed in 2022?

Chemours' stock was trading at $33.56 at the beginning of the year. Since then, CC stock has decreased by 5.5% and is now trading at $31.73.
View the best growth stocks for 2022 here

When is Chemours' next earnings date?

Chemours is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Chemours

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) released its earnings results on Monday, May, 2nd. The specialty chemicals company reported $1.46 EPS for the quarter, topping analysts' consensus estimates of $0.92 by $0.54. The specialty chemicals company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.54 billion. Chemours had a trailing twelve-month return on equity of 76.47% and a net margin of 11.19%. During the same period last year, the company earned $0.71 EPS.
View Chemours' earnings history

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours announced a quarterly dividend on Wednesday, April 27th. Shareholders of record on Monday, May 16th will be given a dividend of $0.25 per share on Wednesday, June 15th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.15%. The ex-dividend date of this dividend is Friday, May 13th.
View Chemours' dividend history

Is Chemours a good dividend stock?

Chemours(NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.19%. The dividend payout ratio of Chemours is 22.27%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Chemours will have a dividend payout ratio of 17.04% next year. This indicates that Chemours will be able to sustain or increase its dividend.
View Chemours' dividend history.

Who are Chemours' key executives?

Chemours' management team includes the following people:

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours CEO Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among Chemours' employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Who are Chemours' major shareholders?

Chemours' stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.63%), Vanguard Group Inc. (10.37%), Sessa Capital IM L.P. (4.52%), State Street Corp (2.97%), LSV Asset Management (2.25%) and Bank of New York Mellon Corp (1.40%). Company insiders that own Chemours stock include Alisha Bellezza, Alvenia Scarborough, Bradley J Bell, David C Shelton, Denise Dignam, E Bryan Snell, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Mary B Cranston, Matthew S Abbott, Richard H Brown and Sameer Ralhan.
View institutional ownership trends for Chemours

Which major investors are selling Chemours stock?

CC stock was sold by a variety of institutional investors in the last quarter, including Sessa Capital IM L.P., Northern Trust Corp, Allianz Asset Management GmbH, Invesco Ltd., Federated Hermes Inc., Prudential Financial Inc., Los Angeles Capital Management LLC, and Vanguard Group Inc.. Company insiders that have sold Chemours company stock in the last two years include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Mark Newman, Mark P Vergnano, Matthew S Abbott, and Sameer Ralhan.
View insider buying and selling activity for Chemours
or view top insider-selling stocks.

Which major investors are buying Chemours stock?

CC stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., First Trust Advisors LP, Massachusetts Financial Services Co. MA, Bank of America Corp DE, Jupiter Asset Management Ltd., Greenlight Capital Inc., State Street Corp, and Jane Street Group LLC.
View insider buying and selling activity for Chemours
or or view top insider-buying stocks.

How do I buy shares of Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $31.73.

How much money does Chemours make?

Chemours (NYSE:CC) has a market capitalization of $4.93 billion and generates $6.35 billion in revenue each year. The specialty chemicals company earns $608 million in net income (profit) each year or $4.489990 on an earnings per share basis.

How many employees does Chemours have?

Chemours employs 6,400 workers across the globe.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The official website for Chemours is www.chemours.com. The specialty chemicals company can be reached via phone at (302) 773-1000 or via email at [email protected].

This page (NYSE:CC) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.